VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
AZTAAzenta, Inc.
$23.31$1.1B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

AZTA logoAzenta, Inc.(AZTA)Earnings, Financials & Key Ratios

AZTA•NASDAQ
Price updated Jun 19, 2026
SectorHealthcareIndustryMedical InstrumentsSub-IndustryDiagnostics and life science tools
AboutAzenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.Show more
  • Revenue$594M+3.6%
  • EBITDA$50M-17.8%
  • Net Income-$56M+66.2%
  • EPS (Diluted)-1.22+60.5%
  • Gross Margin45.52%+2.5%
  • EBITDA Margin8.41%-20.6%
  • Operating Margin-1.9%+63.7%
  • Net Margin-9.39%+67.3%
  • ROE-3.19%+58.4%

AZTA Key Insights

Azenta, Inc. (AZTA) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Company is almost debt free
  • ✓Share count reduced 13.7% through buybacks
  • ✓Trading at only 0.6x book value

✗Weaknesses

  • ✗Trading more than 30% below 52-week high
  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when AZTA posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

AZTA Price & Volume

Azenta, Inc. (AZTA) stock price & volume — 10-year historical chart

Loading chart...

AZTA Growth Metrics

Azenta, Inc. (AZTA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years0.72%
5 Years8.85%
3 Years2.25%
TTM1.85%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-175.49%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-184.89%

Return on Capital

10 Years0.84%
5 Years-1.06%
3 Years-1.53%
Last Year-0.61%

AZTA Recent Earnings

Azenta, Inc. (AZTA) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 9/12 qtrs (75%)●Beat Revenue 8/12 qtrs (67%)
Q2 2026Latest
May 6, 2026
Metric
Actual
Est
EPS
$0.04-140.0%
$0.10
Rev
$145M-2.4%
$148M
Q1 2026
Feb 4, 2026
Metric
Actual
Est
EPS
$0.09-18.2%
$0.11
Rev
$149M+1.1%
$147M
Q4 2025
Nov 21, 2025
Metric
Actual
Est
EPS
$0.21+10.8%
$0.19
Rev
$159M+1.9%
$156M
Q3 2025
Aug 5, 2025
Metric
Actual
Est
EPS
$0.19+46.2%
$0.13
Rev
$144M-8.1%
$157M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 6, 2026
$0.04vs $0.10-140.0%
$145Mvs $148M-2.4%
Q1 2026Feb 4, 2026
$0.09vs $0.11-18.2%
$149Mvs $147M+1.1%
Q4 2025Nov 21, 2025
$0.21vs $0.19+10.8%
$159Mvs $156M+1.9%
Q3 2025Aug 5, 2025
$0.19vs $0.13+46.2%
$144Mvs $157M-8.1%
Based on last 12 quarters of dataView full earnings history →

AZTA Peer Comparison

Azenta, Inc. (AZTA) competitors in Diagnostics and life science tools — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
FROG logoFROGJFrog Ltd.Direct Competitor10.02B82.72-133.4224.12%-10.93%-7.04%0.02
BLFS logoBLFSBioLife Solutions, Inc.Direct Competitor1.27B26.04-104.1616.97%-10.52%-2.91%0.05
ITRN logoITRNIturan Location and Control Ltd.Direct Competitor1.3B65.4922.436.77%16.03%27.71%0.02
CCSI logoCCSIConsensus Cloud Solutions, Inc.Direct Competitor628.11M34.147.85-0.2%25.09%52.86%42.14
QGEN logoQGENQiagen N.V.Product Competitor7.61B36.9518.115.65%20.33%11.85%0.44
PACB logoPACBPacific Biosciences of California, Inc.Product Competitor434.84M1.40-0.773.89%-80.34%-488.45%141.98
FLGT logoFLGTFulgent Genetics, Inc.Product Competitor535.45M18.00-9.1413.83%-18.75%-5.42%0.00
BRKR logoBRKRBruker CorporationProduct Competitor8.71B57.23-381.532.08%-0.34%-0.5%0.81

Compare AZTA vs Peers

Azenta, Inc. (AZTA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs FROG

Most directly comparable listed peer for AZTA.

Scale Benchmark

vs TMO

Larger-name benchmark to compare AZTA against a more recognizable public peer.

Peer Set

Compare Top 5

vs FROG, BLFS, ITRN, CCSI

AZTA Income Statement

Azenta, Inc. (AZTA) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricSep'17Sep'18Sep'19Sep'20Sep'21Sep'22Sep'23Sep'24Sep'25TTM
Sales/Revenue
527.5M631.56M780.85M388.54M513.7M555.5M665.07M573.45M593.82M596.57M
Revenue Growth %
-5.86%19.73%23.64%-50.24%32.21%8.14%19.73%-13.78%3.55%1.85%
Cost of Goods Sold
341.84M404.82M488.82M243.66M299.19M324.88M431.82M318.83M323.54M330.8M
COGS % of Revenue
64.8%64.1%62.6%62.71%58.24%58.48%64.93%55.6%54.48%-
Gross Profit
185.66M▲ 0%
226.74M▲ 22.1%
292.02M▲ 28.8%
144.87M▼ 50.4%
214.51M▲ 48.1%
230.62M▲ 7.5%
233.26M▲ 1.1%
254.62M▲ 9.2%
270.28M▲ 6.1%
265.77M▲ 0%
Gross Margin %
35.2%35.9%37.4%37.29%41.76%41.52%35.07%44.4%45.52%44.55%
Gross Profit Growth %
-0.87%22.13%28.79%-50.39%48.07%7.51%1.14%9.16%6.15%-
Operating Expenses
167.5M192.32M236.89M172.4M210.91M254.64M315.45M284.6M281.55M281.42M
OpEx % of Revenue
31.75%30.45%30.34%44.37%41.06%45.84%47.43%49.63%47.41%-
Selling, General & Admin
127.62M145.38M180.52M156.28M188.5M227.1M281.5M253.08M251.16M247.85M
SG&A % of Revenue
24.19%23.02%23.12%40.22%36.69%40.88%42.33%44.13%42.3%-
Research & Development
39.88M46.94M56.37M16.12M22.41M27.54M33.96M31.52M30.39M33.56M
R&D % of Revenue
7.56%7.43%7.22%4.15%4.36%4.96%5.11%5.5%5.12%-
Other Operating Expenses
0000000000
Operating Income
18.16M▲ 0%
34.42M▲ 89.5%
55.13M▲ 60.2%
-27.53M▼ 149.9%
3.6M▲ 113.1%
-24.02M▼ 768.0%
-82.2M▼ 242.2%
-29.98M▲ 63.5%
-11.27M▲ 62.4%
-15.64M▲ 0%
Operating Margin %
3.44%5.45%7.06%-7.08%0.7%-4.32%-12.36%-5.23%-1.9%-2.62%
Operating Income Growth %
-6.75%89.52%60.16%-149.93%113.06%-768.05%-242.16%63.53%62.42%-
EBITDA
45.36M71.12M109.58M37.97M60.47M29.68M3.39M60.76M49.94M41.14M
EBITDA Margin %
8.6%11.26%14.03%9.77%11.77%5.34%0.51%10.6%8.41%6.9%
EBITDA Growth %
-4.55%56.79%54.07%-65.35%59.25%-50.92%-88.59%1694.54%-17.81%-28.64%
D&A (Non-Cash Add-back)
27.2M36.7M54.45M65.5M56.87M53.7M85.58M90.74M61.21M56.78M
EBIT
14.93M29.99M31.69M-37.35M-46.93M-5.35M-30.43M-19.13M-7.14M-7.61M
Net Interest Income
56K-7.64M-20.8M-2.1M-1.41M15.7M43.73M33.18M18.78M19.48M
Interest Income
464K1.88M1.45M849K632K20.29M43.73M33.18M18.78M19.48M
Interest Expense
408K9.52M22.25M2.94M2.04M4.59M0000
Other Income/Expense
-4.1M-13.96M-45.69M-12.77M-52.56M14.09M51.77M10.86M4.13M-134.03M
Pretax Income
14.07M▲ 0%
20.47M▲ 45.5%
9.44M▼ 53.9%
-40.29M▼ 526.7%
-48.97M▼ 21.5%
-9.94M▲ 79.7%
-30.43M▼ 206.3%
-19.13M▲ 37.2%
-7.14M▲ 62.7%
-149.67M▲ 0%
Pretax Margin %
2.67%3.24%1.21%-10.37%-9.53%-1.79%-4.58%-3.34%-1.2%-25.09%
Income Tax
3.38M-47.25M-111K-13.93M-20.1M1.35M-17.55M5.24M-31.6M-39.79M
Effective Tax Rate %
24.03%-230.88%-1.18%34.57%41.05%-13.59%57.67%-27.4%442.41%26.58%
Net Income
62.61M▲ 0%
116.58M▲ 86.2%
28.82M▼ 75.3%
64.85M▲ 125.1%
110.75M▲ 70.8%
-428.96M▼ 487.3%
-14.26M▲ 96.7%
-164.9M▼ 1056.6%
-55.76M▲ 66.2%
-178.16M▲ 0%
Net Margin %
11.87%18.46%3.69%16.69%21.56%-77.22%-2.14%-28.76%-9.39%-29.86%
Net Income Growth %
190.12%86.19%-75.28%125.06%70.77%-487.33%96.68%-1056.6%66.18%-175.49%
Net Income (Continuing)
10.69M67.72M9.55M-26.36M-28.87M-11.29M-12.88M-24.37M24.46M-109.88M
Discontinued Operations
51.92M48.75M19.26M91.22M139.62M-417.68M-1.37M-140.53M-80.22M-3.78M
Minority Interest
0000000000
EPS (Diluted)
0.89▲ 0%
1.64▲ 84.3%
0.14▼ 91.5%
0.88▲ 528.6%
-0.39▼ 144.3%
-0.15▲ 61.5%
-0.22▼ 46.7%
-3.09▼ 1304.5%
-1.22▲ 60.5%
-3.87▲ 0%
EPS Growth %
188.12%84.27%-91.46%528.57%-144.32%61.54%-46.67%-1304.55%60.52%-184.89%
EPS (Basic)
0.901.650.140.88-0.39-0.15-0.22-3.09-1.22-
Diluted Shares Outstanding
70.48M70.94M72.39M73.85M74.45M74.9M66.25M53.17M45.9M46.06M
Basic Shares Outstanding
69.58M70.49M71.99M73.56M74.23M74.9M66.25M53.17M45.74M46.06M
Dividend Payout Ratio
44.61%24.26%100.27%45.51%26.84%-----

AZTA Balance Sheet

Azenta, Inc. (AZTA) balance sheet — assets, liabilities & shareholders' equity

MetricSep'17Sep'18Sep'19Sep'20Sep'21Sep'22Sep'23Sep'24Sep'25TTM
Total Current Assets
352.01M564.81M648.2M649.45M777.37M2.46B1.42B832.81M708.34M726.99M
Cash & Short-Term Investments
101.65M243.99M335.77M295.72M227.51M1.57B1.02B462.09M340.92M380.52M
Cash Only
101.62M197.71M301.64M295.65M227.43M658.27M678.91M310.93M279.78M234.03M
Short-Term Investments
28K46.28M34.12M67K81K911.76M338.87M151.16M61.14M146.48M
Accounts Receivable
93.47M125.19M165.6M94.79M119.88M163.76M156.53M172.71M189.21M131.32M
Days Sales Outstanding
64.6772.3577.4189.0585.18107.685.91109.93116.396.53
Inventory
106.39M96.99M99.44M114.83M60.4M85.54M128.2M115.26M74.96M78.51M
Days Inventory Outstanding
113.687.4574.25172.0273.6896.11108.36131.9584.5687.29
Other Current Assets
60.67M97.89M0222.86M318.53M507.38M116.44M82.75M103.25M136.64M
Total Non-Current Assets
414.62M531.2M868.86M909.67M1.04B1.26B1.47B1.27B1.35B1.18B
Property, Plant & Equipment
58.46M59.99M100.67M117.67M130.72M154.47M205.74M266.65M208M231.28M
Fixed Asset Turnover
9.02x10.53x7.76x3.30x3.93x3.60x3.23x2.15x2.85x2.76x
Goodwill
233.64M255.88M488.6M501.54M469.36M513.62M784.34M691.41M702.39M552.4M
Intangible Assets
83.52M99.96M251.17M218.32M186.53M178.4M294.3M248.03M101.81M92.11M
Long-Term Investments
31.23M7.24M2.85M3.1M3.6M352.02M111.34M49.45M247.19M848.7M
Other Non-Current Assets
6.07M64.35M20.51M64.07M241.9M57.09M70.47M10.86M91.12M77.19M
Total Assets
766.63M▲ 0%
1.1B▲ 43.0%
1.52B▲ 38.4%
1.56B▲ 2.8%
1.82B▲ 16.7%
3.72B▲ 104.2%
2.89B▼ 22.3%
2.1B▼ 27.2%
2.06B▼ 1.9%
1.9B▲ 0%
Asset Turnover
0.69x0.58x0.51x0.25x0.28x0.15x0.23x0.27x0.29x0.30x
Asset Growth %
11.77%42.96%38.42%2.77%16.7%104.24%-22.35%-27.23%-1.93%-20.28%
Total Current Liabilities
146.78M165.37M272.99M211.12M345.09M230.55M210.93M204.84M237.67M257.19M
Accounts Payable
49.1M44.72M58.92M25.69M42.36M38.65M35.8M44.43M37.72M33.14M
Days Payables Outstanding
52.4340.3243.9938.4851.6843.4330.2650.8742.5640.72
Short-Term Debt
02M829K827K00007.78M0
Deferred Revenue (Current)
24.29M26.63M29.48M31.36M25.72M39.75M34.61M31.98M32.57M168.16M
Other Current Liabilities
39.82M44.79M52.45M111.5M162.12M81.83M99.23M104.5M114.39M176.29M
Current Ratio
2.40x3.42x2.37x3.08x2.25x10.67x6.73x4.07x2.98x2.83x
Quick Ratio
1.67x2.83x2.01x2.53x2.08x10.30x6.12x3.50x2.66x2.52x
Cash Conversion Cycle
125.85119.47107.67222.58107.18160.28164.01191.01158.31143.1
Total Non-Current Liabilities
12.21M212.81M104.77M134.39M149.09M122.19M140.29M126.23M93.02M92.02M
Long-Term Debt
0194.07M50.31M49.59M49.68M00051.24M0
Capital Lease Obligations
00018.91M45.09M49.23M60.44M60.13M52.15M214.04M
Deferred Tax Liabilities
5.43M8.24M38.91M17.8M15M66.24M054.18M18.25M69.82M
Other Non-Current Liabilities
8.46M11.6M15.55M47.9M39.32M6.72M79.86M11.93M-28.61M20.56M
Total Liabilities
158.98M378.18M377.76M345.51M494.18M352.74M351.22M331.07M330.7M349.21M
Total Debt
0196.07M51.14M82.27M94.77M49.23M60.44M70.68M111.17M55.71M
Net Debt
-101.62M-1.64M-250.5M-213.38M-132.66M-609.05M-618.47M-240.25M-168.61M-178.32M
Debt / Equity
-0.27x0.04x0.07x0.07x0.01x0.02x0.04x0.06x0.04x
Debt / EBITDA
-2.76x0.47x2.17x1.57x1.66x17.85x1.16x2.23x1.35x
Net Debt / EBITDA
-2.24x-0.02x-2.29x-5.62x-2.19x-20.52x-182.66x-3.95x-3.38x-4.33x
Interest Coverage
36.59x3.15x1.42x-12.69x-23.04x-1.17x----
Total Equity
607.64M▲ 0%
717.83M▲ 18.1%
1.14B▲ 58.7%
1.21B▲ 6.5%
1.33B▲ 9.2%
3.36B▲ 153.8%
2.53B▼ 24.6%
1.77B▼ 30.2%
1.73B▼ 2.4%
1.55B▲ 0%
Equity Growth %
9.74%18.13%58.71%6.52%9.21%153.78%-24.64%-30.2%-2.37%-27.37%
Book Value per Share
8.6210.1215.7416.4317.8044.9138.2533.2737.6333.75
Total Shareholders' Equity
607.64M717.83M1.14B1.21B1.33B3.36B2.53B1.77B1.73B1.55B
Common Stock
833K841K857K873K878K885K713K590K594K596K
Retained Earnings
-1.08B-994.07M-586.08M-551.07M-470.05M1.66B1.64B1.48B1.42B1.24B
Treasury Stock
-200.96M-200.96M-200.96M-200.96M-200.96M-200.96M-200.96M-200.96M-200.96M-200.96M
Accumulated OCI
15.21M13.59M3.51M21.92M19.35M-83.92M-62.43M-13.46M-22.21M-27.47M
Minority Interest
0000000000

AZTA Cash Flow Statement

Azenta, Inc. (AZTA) cash flow — operating, investing & free cash flow history

MetricSep'17Sep'18Sep'19Sep'20Sep'21Sep'22Sep'23Sep'24Sep'25TTM
Cash from Operations
96.22M73.96M90.9M37.87M149.86M-466.05M5.83M49.74M72.18M61.01M
Operating CF Margin %
18.24%11.71%11.64%9.75%29.17%-83.9%0.88%8.67%12.16%-
Operating CF Growth %
143.32%-23.13%22.89%-58.34%295.76%-410.99%101.25%752.64%45.11%34.29%
Net Income
62.61M116.46M437.42M64.85M110.75M2.13B-14.64M-164.9M-55.76M-178.16M
Depreciation & Amortization
28.15M37.43M54.45M65.5M65.33M53.7M85.58M90.74M61.21M56.81M
Stock-Based Compensation
17.28M19.82M20.11M16.32M27.46M10.67M9.38M14.47M20.88M17.85M
Deferred Taxes
517K-45.22M-15.16M-5.41M-17.27M24.47M-28.74M-15.89M-27.04M-30.45M
Other Non-Cash Items
-11.64M-7.94M-411.12M-90.72M14.8M-2.62B-16.71M122.28M95.73M230.62M
Working Capital Changes
-691K-46.59M5.19M-12.67M-51.21M-72.73M-29.04M3.04M-22.84M-35.61M
Change in Receivables
-11.18M-29.21M-11.45M-18.75M-69.64M-31.4M34.46M-12.07M-24.56M-22.73M
Change in Inventory
-12.79M-24.36M-2.93M-13.14M-50.44M-66.63M8.25M15.9M-2.67M-3.34M
Change in Payables
7.85M5.46M4.7M792K30.97M-3.93M-14.71M9.2M1.04M-5.21M
Cash from Investing
-54.19M-148.47M211.31M-22.74M-146.35M1.47B431.38M224.74M-90.46M-105.52M
Capital Expenditures
-12.92M-12.79M-23.86M-39.92M-52.8M-73.44M-39.44M-37.39M-33.86M-32.29M
CapEx % of Revenue
2.45%2.02%3.06%10.28%10.28%13.22%5.93%6.52%5.7%5.41%
Acquisitions
-44.79M-85.75M218.94M-15.74M-95.51M2.81B-386.51M00-9.69M
Investments
----------
Other Investing
100K200K0-1M2M-4M0009M
Cash from Financing
-25.92M170.28M-191.16M-27.02M-25.91M-62.76M-840.46M-659.21M-9.59M-963K
Debt Issued (Net)
0196.05M-165M-2.1M-1.99M-50.11M-578K-783K-985K-939K
Equity Issued (Net)
2.04M2.83M3.42M4.59M5.81M5.25M-834.89M-658.42M2.77M2.4M
Dividends Paid
-27.93M-28.29M-28.89M-29.51M-29.73M-7.49M0000
Share Repurchases
000000-838.51M-661.7M00
Other Financing
-28K-318K-687K00-10.4M-4.99M0-11.38M-2.42M
Net Change in Cash
16.54M▲ 0%
96.09M▲ 481.1%
107.46M▲ 11.8%
-2.65M▼ 102.5%
-17.19M▼ 550.0%
755.96M▲ 4496.9%
-357.25M▼ 147.3%
-363.06M▼ 1.6%
-24.3M▲ 93.3%
-39.58M▲ 0%
Free Cash Flow
83.31M▲ 0%
61.18M▼ 26.6%
67.04M▲ 9.6%
-2.06M▼ 103.1%
97.05M▲ 4815.8%
-543.48M▼ 660.0%
-33.6M▲ 93.8%
12.35M▲ 136.8%
38.32M▲ 210.3%
28.72M▲ 0%
FCF Margin %
15.79%9.69%8.59%-0.53%18.89%-97.84%-5.05%2.15%6.45%4.81%
FCF Growth %
212.02%-26.56%9.58%-103.07%4815.84%-659.99%93.82%136.76%210.29%-10.29%
FCF per Share
1.180.860.93-0.031.30-7.26-0.510.230.840.62
FCF Conversion (FCF/Net Income)
1.54x0.63x3.15x0.58x1.35x1.09x-0.41x-0.30x-1.29x-0.16x
Interest Paid
200K6.54M20.8M2.16M1.44M469K0000
Taxes Paid
8.14M21.05M16.99M102.01M38.02M452.46M43.07M2.7M6.57M6.42M

AZTA Key Ratios

Azenta, Inc. (AZTA) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)
10.78%17.59%3.1%5.51%8.72%-18.3%-0.48%-7.66%-3.19%-10.69%
Return on Invested Capital (ROIC)
2.8%4.22%5.15%-2.19%0.25%-0.91%-2.64%-1.31%-0.55%-0.81%
Gross Margin
35.2%35.9%37.4%37.29%41.76%41.52%35.07%44.4%45.52%44.55%
Net Margin
11.87%18.46%3.69%16.69%21.56%-77.22%-2.14%-28.76%-9.39%-29.86%
Debt / Equity
-0.27x0.04x0.07x0.07x0.01x0.02x0.04x0.06x0.04x
Interest Coverage
36.59x3.15x1.42x-12.69x-23.04x-1.17x----
FCF Conversion
1.54x0.63x3.15x0.58x1.35x1.09x-0.41x-0.30x-1.29x-0.16x
Revenue Growth
-5.86%19.73%23.64%-50.24%32.21%8.14%19.73%-13.78%3.55%1.85%
Related:AZTA Dividend History·AZTA Revenue History·AZTA Price History·AZTA P/E History·AZTA Financial Ratios·AZTA Institutional Holders

AZTA SEC Filings & Documents

Azenta, Inc. (AZTA) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 5, 2026·SEC

Material company update

Apr 7, 2026·SEC

Material company update

Apr 2, 2026·SEC

10-K Annual Reports

3
FY 2025

Dec 4, 2025·SEC

FY 2024

Nov 27, 2024·SEC

FY 2023

Nov 21, 2023·SEC

10-Q Quarterly Reports

6
FY 2026

May 8, 2026·SEC

FY 2026

Feb 5, 2026·SEC

FY 2025

Aug 6, 2025·SEC

AZTA Frequently Asked Questions

Azenta, Inc. (AZTA) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Azenta, Inc. (AZTA) reported $596.6M in revenue for fiscal year 2025. This represents a 560% increase from $90.4M in 1996.

Azenta, Inc. (AZTA) grew revenue by 3.6% over the past year. Growth has been modest.

Azenta, Inc. (AZTA) reported a net loss of $178.2M for fiscal year 2025.

Dividend & Returns

Azenta, Inc. (AZTA) has a return on equity (ROE) of -3.2%. Negative ROE indicates the company is unprofitable.

Azenta, Inc. (AZTA) generated $28.7M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in AZTA back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →

How much would $100/month in AZTA be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →